Volz H P, Gleiter C H, Möller H J
Psychiatrische Klinik, Friedrich-Schiller-Universität, Jena.
Nervenarzt. 1996 May;67(5):339-47.
With the introduction of moclobemide as the first reversible and selective inhibitor of monoamine oxidase (type A), the therapeutic principle of monoamine oxidase inhibition gained new importance. In this paper the clinical pharmacology, efficacy and side effects of traditional monoamine oxidase inhibitors and specifically of tranylcypromine as an example) are compared with those of the reversible and selective monoamine oxidase inhibitors (as exemplified by moclobemide).
随着作为首个可逆性和选择性单胺氧化酶（A型）抑制剂的吗氯贝胺的引入，单胺氧化酶抑制的治疗原则有了新的重要意义。本文将传统单胺氧化酶抑制剂（以反苯环丙胺为例）以及可逆性和选择性单胺氧化酶抑制剂（以吗氯贝胺为例）的临床药理学、疗效及副作用进行了比较。
